Status: Not yet recruiting
Clinical Investigation of Safety and Effectiveness for the enVVe® System
A staged prospective, randomized, non-blinded, multicenter study.
Participants needed: 220
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Hancock Jaffe Laboratiores, IncUpdated: May 27, 2026
Eligibility criteria
Persistent symptoms with at least 3 months of routine care including compression... [+15]
Known hypercoagulable condition including Factor V Leiden deficiency (homozygote... [+32]